IP Library Granted Patent US 8,383,170
Granted Patent B2
US 8,383,170 · App. 13/291,670 · Granted Feb 26, 2013

Mucosal formulation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,383,170
App. No.
13/291,670
Granted
Feb 26, 2013
Kind
B2
Abstract

Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea ; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s).

Claims (14)

1. A method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to oral mucosa at or adjacent to disease affected tissue a formulation comprising

an anti-gingivitis effective amount of herbal extracts including Sambucus nigra, Centella asiatica and Echinacea purpurea defining a weight amount of plant extract solids in the formulation, wherein Sambucus nigra extract is more than 50% to 90% by weight of the plant extract solids and Centella asiatica is 1% to less than 50% by weight of the plant extract solids,

a plasticizer in an amount from 10 to 45% by weight of the formulation, and

an antimicrobially effective amount of a surfactant that is a 1-alkylpyridinium salt, where alkyl is C8-C36, the surfactant present in an amount from 0.01 to 2% of the formulation by weight.

2. The method of claim 1 , further comprising applying to a portion of the mucosa a film, patch or an adhesive solid formulation comprising a composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea .

3. The method of claim 1 , wherein the 1-alkylpyridinium salt is a cetylpyridinium salt.

4. The method of claim 1 , wherein Sambucus nigra extract comprises 60 to 99% by weight of plant extract solids in the formulation.

5. The method of claim 1 , wherein the surfactant is present in an amount from 0.01 to 1% of the formulation by weight.

6. The method of claim 4 , wherein Centella asiatica extract comprises 5 to 40% by weight of plant extract solids in the formulation.

7. The method of claim 6 , wherein the surfactant is present in an amount from 0.01 to 1% of the formulation by weight.

8. The method of claim 6 , wherein Echinacea purpurea extract comprises 1 to 20% by weight of plant extract solids in the formulation.

9. The method of claim 1 , wherein Centella asiatica extract comprises 5 to 40% by weight of plant extract solids in the formulation.

10. The method of claim 1 , wherein Echinacea purpurea extract comprises 1 to 20% by weight of plant extract solids in the formulation.

11. The method of claim 1 , wherein the formulation is essentially free of added synthetic polymers.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 19, 2025
From: IZUN PHARMACEUTICALS CORPORATION
To: KALMAN, JONATHAN, MR.
Reel/Frame 071152/0608 →
SECURITY INTEREST Recorded Jun 30, 2021
From: IZUN PHARMACEUTICALS CORPORATION
To: JONATHAN KALMAN
Reel/Frame 056716/0583 →
RELEASE OF SECURITY INTEREST Recorded Jan 8, 2019
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 047934/0363 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBERS 14193345 AND 15006421 PREVIOUSLY RECORDED AT REEL: 040824 FRAME: 0202. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Dec 28, 2017
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 045032/0099 →
SECURITY AGREEMENT Recorded Dec 6, 2016
From: IZUN PHARMACEUTICALS CORPORATION
To: HAHN, ELLIOT F
Reel/Frame 040824/0202 →